Short answer
Astrana Health, Inc. (ASTH) filed an 8-K current report with the SEC on March 2, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events). Q1 2025 earnings results disclosed via press release (Exhibit 99.1): refer to exhibit for all financial figures.
Astrana Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2025 earnings results disclosed via press release (Exhibit 99.1): refer to exhibit for all financial figures
- Filing structured as Reg FD-compliant disclosure; press release not subject to Section 18 liability
- Astrana Health (ASTH) operates value-based care physician networks: earnings reflect managed care revenue trends
Item 7.01 · Regulation FD Disclosure
- Astrana Health furnishing Reg FD disclosure: signals management is sharing material non-public info with the broader market to ensure fair access
- Filing explicitly "not filed" under Exchange Act Section 18: limits shareholder litigation liability for the disclosed information
- Content of the actual disclosure resides in an accompanying exhibit (not reproduced in item text): investors should review the exhibit for substantive details
Item 8.01 · Other Events
- Buyback authorization doubled from $50M to $100M, signaling board confidence in stock's intrinsic value
- 633,844 shares repurchased in Q4 2025; $35.9M remained under old program as of Dec 31, 2025
- No expiration date on repurchase program; flexible execution via open market, 10b5-1, or block transactions
- Forward-looking statements flag a material weakness in internal controls and delayed 2025 10-K filing: key risk for investors
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Astrana Health, Inc. 8-K filings
Get the next ASTH 8-K as it lands
Follow ASTH for push alerts, or ask the research agent what this filing means.